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Pharmaceuticsa b s t r a c t
The absolute configuration of a chiral molecule is key to its biological activity. Being able to find out what
this configuration is, is thus crucial for a wide range of applications. The difficulties associated with such
a determination steeply rise as the number of chiral centers in a given compound becomes larger.
Concurrently, it becomes increasingly more challenging to determine the levels and identity of potential
stereochemical contaminants in a given sample with one and the same technique, leading in practice to
extensive and laborious efforts employing multiple analytical techniques. Here, experimental and
theoretical studies based on Vibrational Circular Dichroism (VCD) are presented for dydrogesterone, a
synthetic drug employed in reproductive medicine that is a prototypical example of such a multi-center
chiral compound. We show that our approach allows us to distinguish and assign its absolute configu-
ration without prior knowledge to one of the 64 possible stereoisomers associated with the six chiral
centers. Studies on mixtures of dydrogesterone and 6-dehydroprogesterone, one of the diastereomers of
dydrogesterone and generally the dominant impurity of dehydrogesterone, show that we can identify
the presence of both compounds from one single VCD spectrum. Moreover, we find that we can
determine diastereomeric contamination levels as low as 5% from the experimental VCD spectra.
© 2019 Elsevier B.V. All rights reserved.olecular Sciences, University of Amsterdam, Science Park 904, 1098 XH, Amsterdam, the Netherlands.
M.A.J. Koenis et al. / Analytica Chimica Acta 1090 (2019) 100e105 1011. Introduction techniques that promises to accomplish such a task is Vibrational
Circular Dichroism (VCD) [13e16], whose differential nature leadsDydrogesterone is a synthetic derivative of progesterone (6-
dehydroretro-progesterone) that has been developed and
patented by Westerhof et al. in the early sixties [1e3]. Since then it
has been commercially available as a medicine against progester-
one deficiency. The structure of dydrogesterone differs fromnatural
progesterone by the inversion of two of its chiral centers (C9 and
C10) and the double bond between C6 and C7 (see Fig. 1a). This gives
dydrogesterone a more rigid and bent shape than progesterone,
and causes it to be much more selective towards the progesterone
receptor [4e6]. Unlike other forms of progesterone, dydrogester-
one therefore has no or very limited affinity towards other hor-
mone receptors, does not induce an increase in core temperature,
and also is not contraceptive. The main medicinal usages of
dydrogesterone are to counter infertility due to luteal insufficiency
[7], menstrual disorders [8] and miscarriages [9e11].
Dydrogesterone has 6 chiral centers (C8, C9, C10, C13, C14, and C17)
causing it to have 26¼ 64 stereoisomers. Because of its different
spatial structure, each of these stereoisomers has a different
binding strength to hormone receptors, and will thus affect human
health differently. For pharmaceutical applications it is therefore of
key importance (i) to ensure that the correct stereoisomer has been
synthesized and (ii) to be able to quantify levels of possible dia-
stereomeric impurities. Typically, diastereomers are distinguished
using the torsional angle dependence of coupling constants in 1H
NMR [12], which is then followed up with a chiral spectroscopic
technique to distinguish the enantiomers. However, this approach
fails for dydrogesterone as the molecule has several quartenary
carbon centers that cannot be distinguished with 1H NMR alone.
Ideally, onewould like to be able to assign the diastereomers of a
chiral compound using a single spectroscopic technique, but this
has so far proven to be far from trivial. One of the very fewFig. 1. a) Structure of dydrogesterone ((8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-
dimethyl-1,2,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-
one). b) Structure of 6-dehydroprogesterone ((8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-
dimethyl-1,2,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-
one).to positive and negative bands with frequencies, signs, and
strengths that are very sensitive to the finer details of the confor-
mational and enantiomeric structures. Indeed, in literature there
are examples where VCD has been used to distinguish between
small numbers of diastereomers [17e24]. However, for molecules
with multiple chiral centers this is not straightforward and often
requires the use of more than one chiroptical technique [25,26].
Moreover, since the assignment of the absolute configuration is
based on a comparison between experimentally measured and
theoretically predicted spectra, a emore than usuale careful eval-
uation of the agreement between experiment and theory is needed
for molecules with many stereoisomers.
Besides knowing the dominant absolute configuration, industry
is also required to guarantee that there are no significant amounts
of isomeric contaminations. Typically, this is achieved by chro-
matographic methods like chiral high-performance liquid chro-
matography [27]. However, considering the large number of
stereoisomers of dydrogesterone, a full separation is quite labor-
intensive, if possible at all. It is therefore important to be able to
test the purity of dydrogesterone independently by other analytical
techniques. Because of its high stereoisomeric sensitivity, VCD
could in principle be used as such a method, but as yet examples in
literature where VCD has been employed to this purpose on dia-
stereomeric mixtures are scarce [28]. Based on the known phar-
maceutical synthetic routes [3,29,30] the diastereomer 6-
dehydroprogesterone (see Fig. 1b) is amongst the most likely im-
purity candidates in the case of dydrogesterone. It is therefore of
particular interest to determine how accurately the presence of this
diastereomer can be determined.
In this work we present extensive VCD studies of dydrogester-
one and diastereomeric mixtures. We show that we can unam-
biguously distinguish dydrogesterone amongst all possible
stereoisomers on the basis of the overlap between the experi-
mental and theoretically predicted VCD spectra for the various
stereoisomers. In addition, we demonstrate that concentrations as
low as 5% of a diastereomeric impurity can still be established using
VCD spectroscopy. These studies argue for the further exploration,
development and use of VCD not only to characterize the stereo-
chemistry of compounds but for quantitative analytical applica-
tions as well.
2. Materials and methods
Vibrational absorption (VA) and VCD spectra were measured
using a Bruker Vertex 70 spectrometer in combination with a PMA
50 module for polarization modulation measurements. Dydroges-
terone was purchased from Sigma-Aldrich with European Phar-
macopoeia (EP) Reference Standard (Y0-001004), while 6-
dehydroprogesterone was ordered from TCI and had a purity
higher than 98%. The samples were dissolved in deuterated chlo-
roform at a concentration of 0.4M and measured in a 0.56 mm CaF
transmission cell for 6e8 h. The measurements were performed
with a resolution of 4 cm1 and the central frequency was set at
1400 cm1. Six different samples have been measured: pure
dydrogesterone, pure 6-dehydroprogesterone and four mixtures of
dydrogesterone and 6-dehydro-progesterone with ratios of 5:95,
15:85, 25:75 and 47:53.
A conformational search was performed on 32 stereoisomers of
dydrogesteron using the RDkit module incorporated into the
Amsterdam Density Functional (ADF) software package (2015,
r48476) [31e34]. The 32 enantiomeric pairs of these stereoisomers
yield identical VA and mirror-imaged VCD spectra. For each ste-
reoisomer 1000 conformers were generated and subsequently
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ergy range of 10 kcal/mol and with a minimum root mean square
difference of 0.1. Subsequently, geometry optimizations and VCD
calculations were done using Density Functional Theory (DFT) with
ADF at the TZP/BP86 level of theory [36e39]. For comparison with
the experimental spectra the computed VA and VCD intensities
were convoluted with a Lorenzian function using a full half-width
at half-maximum of 8 cm1 and the computed frequencies were
scaled using the method developed by Shen et al. [40] (see SI
Section 1 for further details). The resulting spectra were
Boltzmann-weighted using the relative bonding energies. Spectral
overlaps were computed with the SimIR and SimVCD measures
[40,41] given by
SimIR ¼ Iab










in which FaðnÞ and FbðnÞ are the two spectra that are compared at
frequencies n. SimIR can have a value between 0 and 1 while the
range of SimVCD is between 1 and 1. Two enantiomers thus have
computed VA and VCD spectra with a SimIR of 1 and a SimVCD
of 1, respectively.
3. Results and discussion
Fig. 2a displays the experimental and theoretically predicted VA
and VCD spectra of dydrogesterone. Overall the spectra show a very
good agreement in the region from 1050 to 1500 cm1. The C¼C
and C¼O stretch region of the VCD spectrum turned out to be much
more difficult to measure accurately due to a low dissimilarity
factor g [42] and this region has therefore been omitted from the
comparison with theory (see SI Fig. S2a for the full VA and VCD
spectra). The calculations show that at room temperature threeFig. 2. Comparison between the experimental (black) and computed (red) VA (bottom) an
pretation of the references to color in this figure legend, the reader is referred to the Webconformations of dydrogesterone contribute dominantly to the
experimental spectra. Using Boltzmann weights as derived from
the calculated conformational energies at the TZP/BP86 level of
theory we find overlaps between the experimental and computed
spectra of 0.83 and 0.65 for the VA and VCD spectra, respectively.
Fig. 2b displays the experimental and theoretically predicted VA
and VCD spectra in the 1050e1500 cm1 region of one of the other
diastereomers, 6-dehydroprogesterone, with the full spectrum up
to 1800 cm1 being reported in SI Fig. S2b. Similar to the case of
dydrogesterone, the calculations of 6-dehydroprogesterone indi-
cate that only three conformations are predominantly present in
experiment. Importantly, its VCD spectrum is strikingly different
from that of dydrogesterone, illustrating the resolving power of the
technique. In this case the comparison between experimental and
theoretical VA and VCD spectra leads to overlap values of 0.86 and
0.68, respectively. Both diastereomers thus show an excellent
agreement between theory and experiment. The SimVCD values are
much higher than the lower limit of 0.4 for enantiomeric discrim-
ination [43] indicating that we can assign the absolute configura-
tion of the two compounds with high confidence.
To determine to what extent VCD allows one to distinguish not
only these two diastereomers, but also yield an assignment with
high confidence value when all 64 stereoisomers are considered,
we simulated the VA and VCD spectra of all these stereoisomers in
the same way as was done for dydrogesterone and 6-
dehydroprogesterone, that is, frequencies were optimally scaled
to the experimental frequencies of each stereoisomer individually
[40] (see SI section S1 for further details). The resulting overlaps are
shown in Fig. 3. As expected the VA spectra of the stereoisomers
show only minor variations in the overlaps thus making it impos-
sible to come to an unambiguous assignment of the absolute
configuration of the stereocenters. The VCD overlaps, on the other
hand, show that dydrogesterone has a significantly higher overlap
than the other stereoisomers. In fact, the next-best performing
diastereomer of dydrogesterone (the (8R,9S,10S,13R,14R,17S)
configuration) has a overlap of 0.34, which is almost two times
lower than dydrogesterone (see SI Fig. S3 for a comparison of the
calculated VCD spectrum of the (8R,9S,10S,13R,14R,17S) diaste-
reomer with the experimental spectrum of dydrogesterone). The
experimental VCD spectrum thus allows for an unambiguous
assignment of the stereochemical configuration of the compound
amongst the 64 possible stereoisomers. A similar analysisd VCD (top) spectra of (a) dydrogesterone and (b) 6-dehydroprogesterone. (For inter-
version of this article.)
Figure 3. Overlap between computed spectra for all stereoisomers of dydrogesterone
and the experimental spectra of dydrogesterone with (a) showing SimIR overlaps for
VA spectra and (b) SimVCD overlaps for VCD spectra. Overlaps are only shown for
enantiomers with a positive SimVCD, the opposite enantiomer giving the same SimVA
and the same but negative SimVCD. The different stereoisomers are indicated by the R
or S configuration of their chiral centers (respectively C8, C9, C10, C13, C14 and C17, see
Fig. 1). The red line indicates the lower limit usually taken for enantiomeric discrim-
ination [43].
Fig. 4. Experimental VA and VCD spectra of mixtures of dydrogesterone and 6-
dehydrogesterone. The colors purple , blue , green , yellow , orange
and red correspond to dydrogesterone:6-dehydrogesterone ratios of 0:100, 5:95,
15:85, 25:75, 47:53 and 100:0 respectively. (For interpretation of the references to
color in this figure legend, the reader is referred to the Web version of this article.)
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conclusions. Also here the 6-dehydroprogesterone isomer has a
much larger VCD overlap than the other diastereomers (see SI
Fig. S4). Interestingly, for 6-dehydroprogesterone we find that the
next-best performing diastereomer has an overlap of 0.42 indi-
cating that the lower limit of 0.40 taken for enantiomeric
discrimination does not always suffice to discriminate between
diastereomers [43].
A further assessment on how well VCD is able to distinguish
between diastereomers has been made by studies of mixtures of 6-
dehydrogesterone with 0, 5, 15, 25, 47, and 100% dydrogesterone.
From Fig. 4, in which the experimental VA and VCD spectra for
these mixtures are shown, it can be concluded that there is a clear
correlation between the spectra and the dydrogesterone:6-
dehydroprogesterone ratio. It is clear therefore that VCD can
distinguish between the different mixtures on a qualitative level.
From an industrial quality control point of view it is key to see to
what extent VCD is able to determine diastereomeric impurity
levels at a quantitative level. To this purpose we have first tested
howwell VCD can identify the compounds in the mixtures without
any prior knowledge, that is, we start with the assumption that in
principle all 64 stereoisomers might be present in the mixture. Thecontribution of each stereoisomer was then determined using a
genetic algorithm that fits the experimental spectra with the 64
computed VCD spectra [44]. Since there are only about 15 main
bands in the experimental spectrum, it is clear that for over-fitting
reasons one should be cautious in using the fitted weights as rep-
resenting the actual stereoisomeric weights. Nevertheless, the
fitted weights can be used as an indication for the stereoisomeric
composition associated with a measured spectrum. For example,
when the spectra of pure dydrogesterone and pure 6-
dehydroprogesterone are fitted, main contributions of 74 and 86%
respectively, are indeed found for dydrogesterone and 6-
dehydroprogesterone. Thus, without any prior knowledge on the
configuration of the six stereocenters the fit to the experimental
VCD spectrum identifies the correct stereoisomers. Even more
impressively, the fit finds for the 47:53mixture dydrogesterone and
6-dehydroprogesterone as the two main components with contri-
butions of 32 and 40%, respectively. Interestingly, the fits find as the
third component the all-(S) configuration, which happens to be an
epimer of both dydrogesterone and 6-dehydroprogesterone.
Because of the previously indicated overfitting, the fit did not
convincingly identify the presence of dydrogesterone in the mix-
tures with lower dydrogesterone concentrations. We therefore
conclude that the VCD spectra are diastereomeric specific enough
to be able to distinguish and identify two stereoisomers in one
spectrum as long as the two stereoisomers have about the same
concentration.
To obtain a quantitative assessment of the diastereomeric dif-
ferentiation, we have fitted the experimental VCD spectra of the
mixtures using only the computed spectra of pure dydrogesterone
and 6-dehydroprogesterone and not those of the other 62 stereo-
isomers. As a further check the experimental spectra of the mix-
tures have also been fitted using the experimental spectra of pure
dydrogesterone and 6-dehydroprogesterone. The results of these
fits are given in Table 1while the corresponding spectra are given in
Table 1
Results of fits of experimental VCD spectra of mixtures of dydrogesterone and 6-dehydrogesterone. The Computational-I columns refer to a fit using the full computed spectra
of dydrogesterone and 6-dehydrogesterone, the Computational-II columns to similar fits but excluding the 1330e1350 cm1 region, while the Experimental columns report fits
using the experimental spectra of the pure compounds. Reference overlap refers to the overlap between the experimental spectrum and a spectrum constructed from the
calculated (or experimental) spectra of the pure compounds with the experimental mixing ratio. Ratios are given as dydrogesterone:6-dehydroprogesterone.
Mixing ratio Computational-I Computational-II Experimental
Fitted ratio Fitted overlap Reference overlap Fitted ratio Fitted overlap Reference overlap Fitted ratio Fitted overlap Reference overlap
0:100 0:100 0.6808 0.6808 0:100 0.8451 0.8451 0:100 1.0000 1.0000
5:95 0:100 0.7145 0.6992 0:100 0.8296 0.8289 8:92 0.9688 0.9685
15:85 0:100 0.7461 0.7110 5:95 0.8403 0.8357 16:84 0.9667 0.9665
25:75 9:91 0.7486 0.7184 20:79 0.8381 0.8365 28:72 0.9641 0.9627
47:53 43:57 0.7010 0.6979 50:50 0.7700 0.7689 53:47 0.9634 0.9462
100:0 0:100 0.6463 0.6463 0:100 0.6974 0.6974 0:100 1.0000 1.0000
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the overlap between the experimentally recorded VCD spectrum of
a particular mixture and the spectrum constructed by adding the
experimental or computed spectra of the two pure compounds
using the ratio of the pertaining mixture.
The results given in Table 1 are in first instance disappointing
since even at a 15% dydrogesterone concentration no contribution
of dydrogesterone is found, while at a 25% concentration only a 9%
contribution is found. The Table shows at the same time, however,
that the fitted overlap increases for mixing ratios from 0 to 15%
dydrogesterone even though in all cases the fits do not find a
contribution from dydrogesterone. This observation indicates that
adding some component of the experimental VCD spectrum of
dydrogesterone increases the overlap between theory and experi-
ment for 6-dehydroprogesterone. Further inspection of the exper-
imental and computed spectra in Fig. 2 gives further insight into
these result and indicates better ways to perform the fits.
Fig. 2 shows that the highest-intensity band in the VCD spec-
trum of 6-dehydroprogesterone occurring at 1330 cm1 is severely
underestimated by the calculations. The VCD spectrum of dydro-
gesterone, on the other hand, features a band with the opposite
sign at this frequency, and adding a small amount of the dydro-
gesterone spectrum will thus improve the agreement between the
experimental and predicted spectra of 6-dehydroprogesterone.
Accepting that the intensity of the 1330 cm1 band is poorly pre-
dicted argues for fits inwhich this band is not taken into account. As
Table 1 shows this indeed leads to significantly better results. We
now find fitted ratios that are closer to the experimental ones albeit
that for the 5% mixture still no contribution of dydrogesterone is
predicted.
As it is in principle possible to use algorithms in which the
sensitivity of the fits to particular spectral regions is tested and to
exclude on that basis suspect regions, one could use such an
approach to determine the ‘robust’ spectral regions for cases where
it is not knownwhich contamination(s) might be present. However,
it is often the case that one -either because of the synthetic route or
because of data from other analyses-has a fairly good idea on
possible contaminations. In that case it is much more straightfor-
ward to use the experimental spectra of the components to fit to
the spectra of an unknown mixture. This eliminates errors in the
theoretical spectra, leaving just the experimental noise and arti-
facts as potential sources of error. The last three columns in Table 1
indeed show that such fits result in very high overlaps (up to 0.97)
and an excellent prediction of stereoisomeric ratios. Even for the
mixture with only 5% dydrogesterone, an 8% contribution of
dydrogesterone is predicted, indicating that VCD is capable to
analyze diastereomeric compositions with an error of about 3%.
In the present studies we have focused on identifying 6-
dehydroprogesterone as a contaminant in dydrogesterone sam-
ples. Regarding the other diastereomeric contaminants, it is clearthat when the experimental VCD spectrum of a contaminant is
known, the statistical power to identify this contaminant and its
concentrationwill primarily depend on how different the spectrum
of the contaminant is from the spectrum of dydrogesterone. In that
regard themixtures of dydrogesterone and 6-dehydroprogesterone
represent an average situation as their overlap is close to zero
(SimVCD¼0.08), indicating that the two spectra are neither
similar nor the opposite of each other. When experimental spectra
are unknown, the only possibility is to use the theoretically pre-
dicted spectra. In that case the diastereomeric discrimination also
depends on how well the spectrum of the contaminant improves
the differences between theory and calculation of the main com-
pound. This may vary significantly for different stereoisomers and
can be found easily by fitting the experimental spectrum with the
computed spectra of the two diastereomers of interest. For
dydrogesterone, for example, the overlap between the computed
and experimental VCD spectrum increases considerably when 16%
of the spectrum of the (8R,9R,10S,13R,14S,17R) diastereomer is
mixed in (SimVCD increases from 0.65 to 0.69), while for about half
of the diastereomers a potential mixing of the spectra does not lead
to any improvement at all.4. Conclusions
Using dydrogesterone and 6-dehydroprogesterone as proto-
typical examples, the present studies have shown that it is possible
to identify without prior knowledge the absolute configuration of a
molecule with six chiral centers on the basis of its VCD spectrum.
They have moreover shown that VCD can identify the two di-
astereomers correctly from the experimental spectrum of an
equimolar mixture of the two. Further, without explicit knowledge
of the experimental VCD spectrum of dydrogesterone and 6-
dehydroprogesterone and merely using the theoretically calcu-
lated spectra of the compounds, mixing ratios down to 25% could
still be detected. A much better quantification can be obtained
when the experimental spectra of both the contaminant and the
compound of interest are known. Using the experimental spectra to
identify regions in the spectrum that are less well described by
theory can then be used to increase significantly the effectiveness
of diastereomeric detection from the theoretical spectra, although
it still falls short of an analysis using the experimental spectra. In
the latter case it has been shown that contamination levels of 5%
with an uncertainty of 3% can easily be detected. Finally, it should
be noted that the ability to detect stereoisomeric contaminants
varies to a large extent from one stereoisomer to another, and de-
pends significantly on the associated VCD spectra. For pharma-
ceutical and other synthetic industrial applications prior
knowledge on which diastereomer(s) could be formed will thus be
quite useful for VCD analyses of purity levels and quality control.
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